(Q38258246)

1 September 2017

1 reference

title

Neuropathology of multiple system atrophy: new thoughts about pathogenesis (English)

1 reference

1 September 2017

0 references

1 reference

multiple system atrophy

1 reference

Kurt A Jellinger

1

1 reference

1 September 2017

language of work or name

English

0 references

publication date

9 October 2014

1 reference

1 September 2017

1 reference

1 September 2017

volume

29

1 reference

1 September 2017

issue

14

1 reference

1 September 2017

page(s)

1720-1741

1 reference

Multiple system atrophy of the cerebellar type: clinical state of the art.

1 September 2017

cites work

1 reference

Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: impact on determining phenotype spectrum

21 January 2018

1 reference

The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations

21 January 2018

1 reference

The phenotype spectrum of Japanese multiple system atrophy

21 January 2018

1 reference

Widespread alterations of alpha-synuclein in multiple system atrophy

21 January 2018

1 reference

Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).

21 January 2018

1 reference

Recent developments in multiple system atrophy.

21 January 2018

1 reference

Second consensus statement on the diagnosis of multiple system atrophy

21 January 2018

1 reference

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy

21 January 2018

1 reference

Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P.

21 January 2018

1 reference

Clinical outcomes of progressive supranuclear palsy and multiple system atrophy

21 January 2018

1 reference

Multiple system atrophy: a review of 203 pathologically proven cases

21 January 2018

1 reference

Pathology and genetics of multiple system atrophy: an approach to determining genetic susceptibility spectrum

21 January 2018

1 reference

Multiple system atrophy: a clinical and neuropathological perspective

21 January 2018

1 reference

Multiplex families with multiple system atrophy

21 January 2018

1 reference

SNCA variants are associated with increased risk for multiple system atrophy

21 January 2018

1 reference

Genetic players in multiple system atrophy: unfolding the nature of the beast

21 January 2018

1 reference

Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients

21 January 2018

1 reference

Mutations in COQ2 in familial and sporadic multiple-system atrophy

21 January 2018

1 reference

No association of GBA mutations and multiple system atrophy.

21 January 2018

1 reference

Multiple system atrophy and repeat expansions in C9orf72.

21 January 2018

1 reference

Probable multiple system atrophy in a German family

21 January 2018

1 reference

α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?

21 January 2018

1 reference

Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry

21 January 2018

1 reference

Diagnostic accuracy of parkinsonism syndromes by general neurologists

21 January 2018

1 reference

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

21 January 2018

1 reference

21 January 2018

Multiple system atrophy

1 reference

Depletion of putative chemosensitive respiratory neurons in the ventral medullary surface in multiple system atrophy

21 January 2018

1 reference

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study

21 January 2018

1 reference

Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests

21 January 2018

1 reference

The natural history of multiple system atrophy: a prospective European cohort study

21 January 2018

1 reference

Clinical correlates of the pathology underlying parkinsonism: a population perspective.

21 January 2018

1 reference

The role of alpha-synuclein in the pathogenesis of multiple system atrophy

21 January 2018

1 reference

Papp-Lantos inclusions and the pathogenesis of multiple system atrophy: an update

21 January 2018

1 reference

Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy.

21 January 2018

1 reference

Pathological biochemistry of alpha-synucleinopathy

21 January 2018

1 reference

Tubulin seeds alpha-synuclein fibril formation

21 January 2018

1 reference

Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy

21 January 2018

1 reference

The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease

21 January 2018

1 reference

p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy

21 January 2018

1 reference

Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy

21 January 2018

1 reference

Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions

21 January 2018

1 reference

LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions

21 January 2018

1 reference

Parkin Co-Regulated Gene (PACRG) is regulated by the ubiquitin-proteasomal system and is present in the pathological features of Parkinsonian diseases

21 January 2018

1 reference

Accumulation of HtrA2/Omi in neuronal and glial inclusions in brains with alpha-synucleinopathies

21 January 2018

1 reference

PINK1, a gene product of PARK6, accumulates in alpha-synucleinopathy brains

21 January 2018

1 reference

Mutant ubiquitin and p62 immunoreactivity in cases of combined multiple system atrophy and Alzheimer's disease.

21 January 2018

1 reference

Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in α-synucleinopathy.

21 January 2018

1 reference

Association of metallothionein-III with oligodendroglial cytoplasmic inclusions in multiple system atrophy

21 January 2018

1 reference

Cystatin C is differentially involved in multiple system atrophy phenotypes.

21 January 2018

1 reference

Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia.

21 January 2018

1 reference

Alpha-synuclein mRNA expression in oligodendrocytes in MSA.

21 January 2018

1 reference

Alpha-synuclein transfers from neurons to oligodendrocytes

21 January 2018

1 reference

The neuropathology, pathophysiology and genetics of multiple system atrophy

21 January 2018

1 reference

Multiple system atrophy: a primary oligodendrogliopathy.

21 January 2018

1 reference

Cellular pathology in multiple system atrophy

21 January 2018

1 reference

The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology

21 January 2018

1 reference

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

21 January 2018

1 reference

Alpha-synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy

21 January 2018

1 reference

Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 1. Neuronal cytoplasmic inclusions

21 January 2018

1 reference

Argyrophilic ubiquitinated cytoplasmic inclusions of Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy)

21 January 2018

1 reference

Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy

21 January 2018

1 reference

Towards translational therapies for multiple system atrophy

21 January 2018

1 reference

The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems.

21 January 2018

1 reference

A quantitative study of the pathological changes in ten patients with multiple system atrophy (MSA).

21 January 2018

1 reference

An autopsy case of early ("minimal change") olivopontocerebellar atrophy (multiple system atrophy-cerebellar).

21 January 2018

1 reference

P25alpha immunoreactive but alpha-synuclein immunonegative neuronal inclusions in multiple system atrophy.

21 January 2018

1 reference

Multiple system atrophy: alpha-synuclein and neuronal degeneration

21 January 2018

1 reference

Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression.

21 January 2018

1 reference

Microglial activation parallels system degeneration in multiple system atrophy

21 January 2018

1 reference

[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy.

21 January 2018

1 reference

Cell type-specific neuronal loss in the putamen of patients with multiple system atrophy

21 January 2018

1 reference

Neuronal cell loss of the striatonigral system in multiple system atrophy

21 January 2018

1 reference

Compartmental loss of striatal medium spiny neurons in multiple system atrophy of parkinsonian type

21 January 2018

1 reference

Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and its alteration in neostriatal neurodegenerative disorders

21 January 2018

1 reference

Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy.

21 January 2018

1 reference

Dopa resistance in multiple-system atrophy: loss of postsynaptic D2 receptors

21 January 2018

1 reference

Olivopontocerebellar pathology in multiple system atrophy

21 January 2018

1 reference

Alpha-synuclein accumulates in Purkinje cells in Lewy body disease but not in multiple system atrophy

21 January 2018

1 reference

Glial cell line-derived neurotrophic factor-like immunoreactivity in the cerebella of normal subjects and patients with multiple system atrophy

21 January 2018

1 reference

Involvement of precerebellar nuclei in multiple system atrophy

21 January 2018

1 reference

Cerebral cortical pathology of sporadic olivopontocerebellar atrophy

21 January 2018

1 reference

Multiple system atrophy with severe involvement of the motor cortical areas and cerebral white matter.

21 January 2018

1 reference

Multiple system atrophy with remarkable frontal lobe atrophy

21 January 2018

1 reference

Progressive cerebral atrophy in multiple system atrophy.

21 January 2018

1 reference

Clinicopathological study of 35 cases of multiple system atrophy.

21 January 2018

1 reference

Olfactory bulb in multiple system atrophy

21 January 2018

1 reference

Olfaction in pathologically proven patients with multiple system atrophy.

21 January 2018

1 reference

A cross-sectional study contrasting olfactory function in autonomic disorders

21 January 2018

1 reference

Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease.

21 January 2018

1 reference

Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure.

21 January 2018

1 reference

Decrease of neurons in the medullary arcuate nucleus of multiple system atrophy: quantitative comparison with Parkinson's disease and amyotrophic lateral sclerosis.

21 January 2018

1 reference

Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy.

21 January 2018

1 reference

Involvement of medullary serotonergic groups in multiple system atrophy

21 January 2018

1 reference

Preservation of branchimotor neurons of the nucleus ambiguus in multiple system atrophy.

21 January 2018

1 reference

Loss of A5 noradrenergic neurons in multiple system atrophy

21 January 2018

1 reference

Depletion of mesopontine cholinergic and sparing of raphe neurons in multiple system atrophy.

21 January 2018

1 reference

A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study

21 January 2018

1 reference

Differential involvement of hypothalamic vasopressin neurons in multiple system atrophy.

21 January 2018

1 reference

Depletion of ventromedullary NK-1 receptor-immunoreactive neurons in multiple system atrophy

21 January 2018

1 reference

Quantitative study of lateral horn cells in 15 cases of multiple system atrophy

21 January 2018

1 reference

Postganglionic sudomotor denervation in patients with multiple system atrophy

21 January 2018

1 reference

Alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells

21 January 2018

1 reference

Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies.

21 January 2018

1 reference

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

21 January 2018

1 reference

Myelin degeneration in multiple system atrophy detected by unique antibodies

21 January 2018

1 reference

Cerebellar lesions in multiple system atrophy: postmortem MR imaging-pathologic correlations.

21 January 2018

1 reference

Medullo-ponto-cerebellar white matter degeneration altered brain network organization and cortical morphology in multiple system atrophy

21 January 2018

1 reference

Grading of neuropathology in multiple system atrophy: proposal for a novel scale

21 January 2018

1 reference

"Minimal change" multiple system atrophy.

21 January 2018

1 reference

Neuropathology underlying clinical variability in patients with synucleinopathies

21 January 2018

1 reference

Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

21 January 2018

1 reference

Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: a clinicopathological case study.

21 January 2018

1 reference

Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients

21 January 2018

1 reference

Glial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy?

21 January 2018

1 reference

"Preclinical" MSA in definite Creutzfeldt-Jakob disease.

21 January 2018

1 reference

Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch.

21 January 2018

1 reference

Pathological description of a non-motor variant of multiple system atrophy.

21 January 2018

1 reference

Incidental Lewy body disease and preclinical Parkinson disease

21 January 2018

1 reference

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

Visuospatial functions in atypical parkinsonian syndromes

21 January 2018

1 reference

Cognitive function in multiple system atrophy of the cerebellar type.

21 January 2018

1 reference

Executive function differences in multiple system atrophy and Parkinson's disease.

21 January 2018

1 reference

Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration.

21 January 2018

1 reference

Cognitive performance in multiple system atrophy

21 January 2018

1 reference

Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders

21 January 2018

1 reference

A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type

21 January 2018

1 reference

Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group

21 January 2018

1 reference

Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study.

21 January 2018

1 reference

Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy

21 January 2018

1 reference

Clinical and imaging characteristics of dementia in multiple system atrophy

21 January 2018

1 reference

Mild cognitive impairment: ten years later

21 January 2018

1 reference

More frequent Lewy bodies but less frequent Alzheimer-type lesions in multiple system atrophy as compared to age-matched control brains

21 January 2018

1 reference

Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy.

21 January 2018

1 reference

Progressive Supranuclear Palsy and Corticobasal Degeneration

21 January 2018

1 reference

Regional differences in the severity of Lewy body pathology across the olfactory cortex

21 January 2018

1 reference

Concomitant progressive supranuclear palsy and multiple system atrophy: more than a simple twist of fate?

21 January 2018

1 reference

Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease.

21 January 2018

1 reference

Cyclin-dependent kinase 5 and mitogen-activated protein kinase in glial cytoplasmic inclusions in multiple system atrophy

21 January 2018

1 reference

REVIEW: tau protein pathology in Alzheimer's disease and related disorders

21 January 2018

1 reference

Increased tau immunoreactivity in oligodendrocytes following human stroke and head injury.

21 January 2018

1 reference

Tau-positive glial cytoplasmic granules in multiple system atrophy

21 January 2018

1 reference

Interaction between pathogenic proteins in neurodegenerative disorders

21 January 2018

1 reference

Fibrillization of alpha-synuclein and tau in familial Parkinson's disease caused by the A53T alpha-synuclein mutation

21 January 2018

1 reference

Tau protein: relevance to Parkinson's disease

21 January 2018

1 reference

Alpha-synuclein-positive structures in cases with sporadic Alzheimer's disease: morphology and its relationship to tau aggregation.

21 January 2018

1 reference

Atypical protein kinase C in neurodegenerative disease II: PKCiota/lambda in tauopathies and alpha-synucleinopathies.

21 January 2018

1 reference

Pathological alpha-synuclein propagates through neural networks

21 January 2018

1 reference

Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline

21 January 2018

1 reference

Distinct α-synuclein strains differentially promote tau inclusions in neurons

21 January 2018

1 reference

Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases

21 January 2018

1 reference

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

21 January 2018

1 reference

Interaction between α-synuclein and other proteins in neurodegenerative disorders.

21 January 2018

1 reference

Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.

21 January 2018

1 reference

Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies

21 January 2018

1 reference

Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy

21 January 2018

1 reference

TDP-43 is deposited in the Guam parkinsonism-dementia complex brains.

21 January 2018

1 reference

The spectrum of disease in chronic traumatic encephalopathy

21 January 2018

1 reference

TDP-43 pathology occurs infrequently in multiple system atrophy

21 January 2018

1 reference

Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation

21 January 2018

1 reference

Multiple system atrophy and amyotrophic lateral sclerosis in a family with hexanucleotide repeat expansions in C9orf72.

21 January 2018

1 reference

Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy

21 January 2018

1 reference

Alpha-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers

21 January 2018

1 reference

Protein aggregation mechanisms in synucleinopathies: commonalities and differences

21 January 2018

1 reference

Oxidation and nitration of α-synuclein and their implications in neurodegenerative diseases

21 January 2018

1 reference

Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes

21 January 2018

1 reference

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

21 January 2018

1 reference

Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies

21 January 2018

1 reference

The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia

21 January 2018

1 reference

Addition of exogenous α-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous α-synuclein to Lewy body and Lewy neurite-like aggregates.

21 January 2018

1 reference

Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?

21 January 2018

1 reference

The prion hypothesis in Parkinson's disease: Braak to the future

21 January 2018

1 reference

Prion-like spreading of pathological α-synuclein in brain

21 January 2018

1 reference

Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport

21 January 2018

1 reference

Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: a speculative synthesis

21 January 2018

1 reference

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice

21 January 2018

1 reference

Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice

21 January 2018

1 reference

Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.

21 January 2018

1 reference

Transmission of multiple system atrophy prions to transgenic mice

21 January 2018

1 reference

Alpha-synuclein spreading in M83 mice brain revealed by detection of pathological α-synuclein by enhanced ELISA.

21 January 2018

1 reference

Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies

21 January 2018

1 reference

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein

21 January 2018

1 reference

Defined α-synuclein prion-like molecular assemblies spreading in cell culture

21 January 2018

1 reference

Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein

21 January 2018

1 reference

Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice

21 January 2018

1 reference

HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy

21 January 2018

1 reference

Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy

21 January 2018

1 reference

Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread.

21 January 2018

1 reference

Is there a risk of prion-like disease transmission by Alzheimer- or Parkinson-associated protein particles?

21 January 2018

1 reference

TPPP/p25: from unfolded protein to misfolding disease: prediction and experiments

21 January 2018

1 reference

Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies

21 January 2018

1 reference

An unstructured protein with destructive potential: TPPP/p25 in neurodegeneration

21 January 2018

1 reference

A brain-specific protein p25 is localized and associated with oligodendrocytes, neuropil, and fiber-like structures of the CA3 hippocampal region in the rat brain

21 January 2018

1 reference

p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies

21 January 2018

1 reference

The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases

21 January 2018

1 reference

Alpha-synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells.

21 January 2018

1 reference

Phosphorylated α-synuclein in Parkinson's disease

21 January 2018

1 reference

Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.

21 January 2018

1 reference

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

21 January 2018

1 reference

Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy

21 January 2018

1 reference

alpha-synuclein promotes mitochondrial deficit and oxidative stress

21 January 2018

1 reference

Mitochondrial association of alpha-synuclein causes oxidative stress

21 January 2018

1 reference

Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability

21 January 2018

1 reference

Activation of the antioxidant response element in primary cortical neuronal cultures derived from transgenic reporter mice

21 January 2018

1 reference

Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.

21 January 2018

1 reference

Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy

21 January 2018

1 reference

Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy

21 January 2018

1 reference

Parkin co-regulated gene is involved in aggresome formation and autophagy in response to proteasomal impairment

21 January 2018

1 reference

Loss of DARPP-32 and calbindin in multiple system atrophy

21 January 2018

1 reference

Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein

21 January 2018

1 reference

FAS-dependent cell death in α-synuclein transgenic oligodendrocyte models of multiple system atrophy

21 January 2018

1 reference

A role for oligodendrocyte-derived IGF-1 in trophic support of cortical neurons.

21 January 2018

1 reference

Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors

21 January 2018

1 reference

Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?

21 January 2018

1 reference

Nitrated alpha-synuclein and microglial neuroregulatory activities

21 January 2018

1 reference

Synuclein activates microglia in a model of Parkinson's disease

21 January 2018

1 reference

[11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?

21 January 2018

1 reference

Mutant alpha-synuclein overexpression mediates early proinflammatory activity

21 January 2018

1 reference

α-Synuclein Alters Toll-Like Receptor Expression

21 January 2018

1 reference

α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease.

21 January 2018

1 reference

Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia.

21 January 2018

1 reference

Toll-like receptor 4 promotes α-synuclein clearance and survival of nigral dopaminergic neurons

21 January 2018

1 reference

Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

21 January 2018

1 reference

Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia

21 January 2018

1 reference

Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy.

21 January 2018

1 reference

Lipid dysfunction and pathogenesis of multiple system atrophy

21 January 2018

1 reference

Cell death mechanisms in multiple system atrophy.

21 January 2018

1 reference

Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy

21 January 2018

1 reference

Multiple system atrophy: a prototypical synucleinopathy for disease-modifying therapeutic strategies.

21 January 2018

1 reference

Mutant COQ2 in Multiple-System Atrophy

21 January 2018

1 reference

An autopsy case of preclinical multiple system atrophy (MSA-C)

21 January 2018

1 reference

Microglial activation mediates neurodegeneration related to oligodendroglial α-synucleinopathy: Implications for multiple system atrophy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.26052

1 reference

1 September 2017

1 reference